HS
BDSI

HighVista Strategies’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

HighVista Strategies’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-22,600
Closed -$84K – 147
2020
Q3 		$84K Buy
22,600
+11,800
+109% +$50.2K 0.06% 88
2020
Q2 		$47K Hold
10,800
– – 0.04% 97
2020
Q1 		$41K Hold
10,800
– – 0.04% 52
2019
Q4 		$68K Hold
10,800
– – 0.05% 108
2019
Q3 		$45K Buy
+10,800
New +$46.1K 0.03% 125

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighVista Strategies's BDSI Position: Q4 2020 in Review

HighVista Strategies sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2020, closing a stake of 22,600 shares — an estimated $84K sold.

HighVista Strategies first reported a position in BDSI in Q3 2019 and held it in 5 quarters. The position peaked at $84K in Q3 2020. 145 funds tracked by Wall St. Rank hold BDSI as of Q4 2020.

  • HighVista Strategies reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2020 after selling out during the quarter.
  • HighVista Strategies sold 22,600 BioDelivery Sciences International, Inc. shares in Q4 2020, an estimated $84K.
  • HighVista Strategies first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 5 quarters.
  • HighVista Strategies's BioDelivery Sciences International, Inc. position peaked at $84K in Q3 2020.
  • 145 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2020.

Based on HighVista Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.